Amino acid replacement: ?174term.
T19496227R
Y174term | hpo-PA; Y174term | hpo-PB
?174term
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
Adult eyes containing hpoBF33 homozygous somatic clones (induced by the eyFLP method) display overgrowth and folding phenotype.
Homozygous clones in the eye disc result in overgrowth and adults have enlarged and folded eyes.
hpoBF33 mutant eye disc clones exhibit tumorous overgrowth.
Homozygous clones in the eye result in enlarged and folded eyes.
Homozygous clones in the eye show progressive degeneration of photoreceptor cells.
hpoBF33 mutant MARCM clones contain 5-7 cells per clone, compared to 2-3 cells in wild-type clones. These clones contain differentiated absorptive enterocytes and secretory enteroendocrine cells indicating that intestine stem cell differentiation continues as in wild-type. Phospho-His3 staining reveals an increase in the number of mitotic cells within the mutant clones. There is also an increase in the number of mitotic cells outside of the hpoBF33 mutant clones, indicating non-cell-autonomous proliferation.
Adults containing homozygous clones represent 36.4% of the population recovered after clones are induced using the eyFLP method (expected fraction of adults containing mutant clones is 50% if there is no effect of the mutant clones on viability).
hpoBF33 mosaic eyes are significantly larger and often protrude out in folds. Tumourous outgrowths are also seen when clones are induced in other places, including the thorax wing and haltere. When mutant clones are made in the wing disc the size of the clones are significantly larger with more cells than the wild-type twin spots. The cell size is unaffected. More cells posterior to the second mitotic wave are seen to be in M phase than in wild-type.
hpoBF33 has visible | adult stage | somatic clone phenotype, enhanceable by AckUAS.Tag:V5/Scer\GAL4Ubi.PU
hpoBF33 has visible | adult stage | somatic clone phenotype, non-enhanceable by Scer\GAL4Ubi.PU/AckKD.UAS.Tag:V5
hpoBF33 has visible | somatic clone phenotype, suppressible by Scer\GAL4Tub.PU/TgiUAS.Tag:FLAG
hpoBF33 has increased occurrence of cell division | somatic clone | adult stage phenotype, suppressible by domeGD14494/Scer\GAL4NP5130
hpoBF33 has increased occurrence of cell division | somatic clone | cell non-autonomous | adult stage phenotype, suppressible by domeGD14494/Scer\GAL4NP5130
hpoBF33 has increased occurrence of cell division | somatic clone | adult stage phenotype, suppressible by Scer\GAL4NP5130/EgfrGD1654
hpoBF33 has increased cell number | somatic clone | cell autonomous phenotype, suppressible by domeGD14494/Scer\GAL4NP5130
hpoBF33 has increased cell number | somatic clone | cell autonomous phenotype, suppressible by Scer\GAL4NP5130/EgfrGD1654
hpoBF33 has increased cell number | somatic clone | cell non-autonomous phenotype, non-suppressible by domeGD14494/Scer\GAL4NP5130
hpoBF33 has increased cell number | somatic clone | cell non-autonomous phenotype, non-suppressible by Scer\GAL4NP5130/EgfrGD1654
hpoBF33 has increased occurrence of cell division | somatic clone | cell non-autonomous | adult stage phenotype, non-suppressible by Scer\GAL4NP5130/EgfrGD1654
hpoBF33 is a suppressor of increased cell death | somatic clone phenotype of hidGMR.PG
hpoBF33 has eye | adult stage | somatic clone phenotype, enhanceable by AckUAS.Tag:V5/Scer\GAL4Ubi.PU
hpoBF33 has eye | adult stage | somatic clone phenotype, non-enhanceable by Scer\GAL4Ubi.PU/AckKD.UAS.Tag:V5
hpoBF33 has eye | somatic clone phenotype, suppressible by Scer\GAL4Tub.PU/TgiUAS.Tag:FLAG
hpoBF33 has intestinal stem cell | somatic clone phenotype, suppressible by domeGD14494/Scer\GAL4NP5130
hpoBF33 has intestinal stem cell | somatic clone phenotype, suppressible by Scer\GAL4NP5130/EgfrGD1654
hpoBF33 has eye disc | somatic clone phenotype, non-suppressible by par-1HMS00405/Scer\GAL4unspecified
Scer\GAL4Tub.PU, brmGD4507, hpoBF33 has midgut | somatic clone phenotype
Expression of AckScer\UAS.T:SV5\V5 (but not AckKD.Scer\UAS.T:SV5\V5) under the control of Scer\GAL4Ubi.PU in the hpoBF33 homozygous somatic clones induced in the eye tissue significantly enhances the overgrowth phenotype observed in the adult eye containing hpoBF33 clones.
Expression of TgiScer\UAS.T:Zzzz\FLAG under the control of Scer\GAL4tub.PU in hpoBF33 clones in the eye disc results in adults with nearly normal eyes.
Expression of par-1HMS00405 under the control of Scer\GAL4unspecified does not suppress the tumorous overgrowth seen in hpoBF33 mutant eye disc clones.
Expression of brmScer\UAS.T:Zzzz\FLAG under the control of Scer\GAL4tub.PU does not affect the growth of hpoBF33 mutant midgut clones.
Expression of brmGD4507 under the control of Scer\GAL4tub.PU reduces the growth of hpoBF33 mutant midgut clones.
Expressing ykidsRNA.N.Scer\UAS in hpoBF33 mutant MARCM clones (using Scer\GAL4esg-NP5130) reduces the clone size.
Compared with hpoBF33 mutant MARCM clones, hpoBF33 mutant clones expressing domeGD14494 or EgfrGD1654 exhibit reduced clone size. domeGD14494 or EgfrGD1654 expression suppresses the elevated levels of mitosis seen in hpoBF33 MARCM clones but not outside the expression domain of the MARCM clones.
hpoBF33 is rescued by hpoUAS.WT.Tag:FLAG/Scer\GAL4Tub.PU
hpoBF33 is rescued by hpoT195E.UAS.Tag:FLAG/Scer\GAL4Tub.PU
hpoBF33 is partially rescued by Scer\GAL4Tub.PU/hpoM242E.UAS.Tag:FLAG
Expression of hpoScer\UAS.WT.T:Zzzz\FLAG under the control of Scer\GAL4tub.PU almost completely rescues the overgrowth phenotype caused by hpoBF33 clones in the eye.
Expression of hpoT195E.Scer\UAS.T:Zzzz\FLAG under the control of Scer\GAL4tub.PU rescues the overgrowth phenotype caused by hpoBF33 clones in the eye.
Expression of hpoM242E.Scer\UAS.T:Zzzz\FLAG under the control of Scer\GAL4tub.PU partially rescues the overgrowth phenotype caused by hpoBF33 clones in the eye.